Is Sheep Ghee Cardioprotective?
Study Details
Study Description
Brief Summary
Normal volunteers were randomly received Sheep ghee or sunflower oil, and before and after the study lipid profile and HS-CRP were measured.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
During outpatient clinic visits, potentially eligible individuals were screened for enrollment according to the inclusion and exclusion criteria.
Patients were randomly allocated into the treatment and control groups via the blocked randomization method.
The control group received a normal diet for eight weeks with 10 g of sunflower oil. In the treatment group, sunflower oil was replaced with 10 g of sheep ghee.
50 patients in each group were enrollment. Patients' information, including demographic data and the serum levels of fasting blood sugar (FBS), LDL, HDL, triglyceride (TG), and hs-CRP, were recorded in datasheets twice: once before treatment with sheep ghee and once eight weeks later.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: intervention 10 gr Sheep ghee |
Dietary Supplement: sheep ghee
natural sheep ghee, given to patient in a commercial box and intervention group 10 gr per day from sheep ghee
|
Active Comparator: control group 10 gr sunflower oil |
Dietary Supplement: sunflower oil
natural sunflower oil, given to patients in a commercial box and patient use 10 gr of it
|
Outcome Measures
Primary Outcome Measures
- LDL cholesterol [2 months]
serum LDL level in mg/dl
- total cholesterol [2 months]
serum total cholesterol in mg/dl
- HDL cholesterol [2 months]
Serum HDL in mg/dl
- HS-CRP [2 months]
HS-CRP level in picogram/dl
Secondary Outcome Measures
- adverse effect [2 months]
gastrointestinal, skin, allergy
Eligibility Criteria
Criteria
Inclusion Criteria:
- healthy adults, seeking outpatient visit at professor kojuri cardiology clinic
Exclusion Criteria:
-
any history of ischemic heart disease (IHD),
-
coronary artery bypass grafting (CABG)
-
percutaneous intervention (PCI)
-
stroke
-
peripheral vascular diseases
-
use of anti-hyperlipidemic agents
-
unwillingness to participate.
-
Need of tight hyperlipidemia control.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Javad Kojuri | Shiraz | Fars | Iran, Islamic Republic of | 7134814336 |
Sponsors and Collaborators
- Shiraz University of Medical Sciences
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 98-01-01-22054